StemExpress Foundation (EIN 900782885) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

Catherine Dyer

Phone

5306267000

Tax Period

2022-01-01 to 2022-12-31

StemExpress Foundation, founded in 2015, is a small nonprofit in the Medical Research sector that reported $411K in total revenue in fiscal year 2022. Revenue surged 65% from the prior year, signaling strong growth momentum. Expenses of $371K left a modest 10% surplus.

Mission

Our mission is to address, educate, coordinate and provide significant change and improvement from medical research to patient outcomes by educating leaders, elected and appointed officials the importance of medical research, future of medicine and patient advocacy, advocate and support medical research advancement through grants, serve to reduce the burdens of government on organizations when it comes to research, clinical trials and FDA approval.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $408,800

Investment Income $0

Other Revenue $2,272

TOTAL REVENUE $411,072

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $294,228

Other Expenses $370,565

TOTAL EXPENSES $370,565

Year-over-Year Comparison

	2022	2021	Change
Revenue	$411,072	$249,620	+0.6%
Expenses	$370,565	$426,210	-0.1%
Net Income	$40,507	$-176,590	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Catherine Dyer	President	1.00	Officer Director	$0	$0	$0
Angeline Peterson	Secretary	1.00	Officer Director	$0	$0	$0
David Scinto	Treasurer	1.00	Officer Director	$0	$0	$0
Dr Gregory Graves	MD Director	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$411,072	$370,565	$260,501	$40,507
2021	$249,620	$426,210	$222,954	$-176,590
2020	$463,698	$496,081	$38,189	$-32,383
2019	$744,803	$740,378	$108,473	$4,425
2018	$590,842	$620,735	$84,593	$-29,893

StemExpress Foundation